American Home Products (AHP) merges two medical device subsidiaries:
This article was originally published in Clinica
Executive Summary
American Home Products intends to merge its two major medical device companies - Davis & Geck and Sherwood Medical. AHP acquired Davis & Geck through its purchase last year of American Cyanamid. Previously, German company B Braun Melsungen had shown interest in purchasing wound closure specialist Davis & Geck. Morgan Stanley analysts estimate that Davis & Geck had sales of $286 million in 1994 and Sherwood $643 million. Sherwood manufactures surgical, wound care and dental products, laboratory supplies and veterinary devices.
You may also be interested in...
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip